Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History POAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics POAI

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Predictive Oncology Inc

POAI
Current price
0.79 USD 0 USD (0.00%)
Last closed 0.78 USD
ISIN US74039M3097
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 7 530 129 USD
Yield for 12 month -27.52 %
1Y
3Y
5Y
10Y
15Y
POAI
21.11.2021 - 28.11.2021

Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania. Address: 91 43rd Street, Pittsburgh, PA, United States, 15201

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.00 USD

P/E Ratio

Dividend Yield

Financials POAI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures POAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+1 623 817 USD

Last Year

+1 780 093 USD

Current Quarter

+110 310 USD

Last Quarter

+611 585 USD

Current Year

+797 680 USD

Last Year

+1 145 297 USD

Current Quarter

+65 192 USD

Last Quarter

+320 959 USD
EBITDA -9 483 742 USD
Operating Margin TTM -2 073.29 %
Price to Earnings
Return On Assets TTM -73.20 %
PEG Ratio
Return On Equity TTM -490.37 %
Wall Street Target Price 3.00 USD
Revenue TTM 1 729 269 USD
Book Value -0.016 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 2 170.70 %
Dividend Yield
Gross Profit TTM 880 447 USD
Earnings per share -1.43 USD
Diluted Eps TTM -1.43 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation POAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 3.46
Price Sales TTM 4.35
Enterprise Value EBITDA -0.51
Price Book MRQ 1.43

Technical Indicators POAI

For 52 Weeks

0.55 USD 2.99 USD
50 Day MA 0.95 USD
Shares Short Prior Month 105 387
200 Day MA 1.01 USD
Short Ratio 0.47
Shares Short 67 481
Short Percent 1.20 %